Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · IEX Real-Time Price · USD
3.240
-0.090 (-2.70%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $137.52 million as of July 2, 2024. Its market cap has decreased by -71.39% in one year.
Market Cap
137.52M
Enterprise Value
-96.70M
1-Year Change
-71.39%
Ranking
Category
Stock Price
$3.24
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $1.05B to $137.52M, a decrease of -86.89%. That is a compound annual growth rate of -39.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 141.30M | -54.05% |
| Dec 29, 2023 | 307.50M | -50.19% |
| Dec 30, 2022 | 617.30M | -29.87% |
| Dec 31, 2021 | 880.20M | -30.20% |
| Dec 31, 2020 | 1.26B | 20.21% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stereotaxis | 147.10M |
| InfuSystem Holdings | 145.45M |
| Zomedica | 145.03M |
| Elevation Oncology | 143.70M |
| MediWound | 143.25M |
| Adverum Biotechnologies | 142.81M |
| Acumen Pharmaceuticals | 142.39M |
| Cardiol Therapeutics | 140.76M |